Market Overview:
The global reverse transcription polymerase chain reaction (RT-PCR) kits market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for RT-PCR kits in hospitals, diagnostic centers, research laboratories & academic institutes, pharmaceutical & biotechnology companies and others across the globe. Additionally, the rising prevalence of infectious diseases and growing investments in life science research are also propelling the growth of this market. On the basis of type, quantitative reverse transcription polymerase chain reaction (qRT-PCR) kits held a major share of the global RT-PCR kits market in 2017. This segment is projected to grow at a CAGR of 7.8% during the forecast period owing to its high accuracy and sensitivity as compared to other types of RT-PCR kits.
Product Definition:
Reverse transcription polymerase chain reaction (RT-PCR) kits are used to amplify nucleic acids using reverse transcription. The kits can be used to detect and quantify specific sequences of DNA or RNA. RT-PCR is often used in medical diagnostics to detect viruses or other genetic abnormalities.
Quantitative Reverse Transcription Polymerase Chain Reaction Kits:
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is a technique used for measuring the amount of gene or protein of interest in a sample using the DNA as a substrate. This technique has gained popularity owing to its high sensitivity, accuracy, and ease of use.
Digital Reverse Transcription Polymerase Chain Reaction Kits:
Reverse transcription polymerase chain reaction (RT-PCR) is a technique used for the amplification of DNA in which RNA is first transcribed from the original DNA. The reverse transcript of the amplified RNA is then used as a substrate for PCR. This process allows easy and quick detection of gene expression by using specific molecular beacons or probes along with real time PCR technology.
Application Insights:
The research laboratories & academic institutes application segment held the largest revenue share of over 40% in 2017. This is attributed to the rising number of R&D activities being conducted at various institutions across the world. Moreover, an increasing number of researchers involved in molecular biology and bioinformatics has fueled demand for these kits. The hospitals application segment is expected to witness a lucrative CAGR during forecast years owing to its growing use in diagnosis and testing procedures for various diseases, including influenza A & B, hepatitis A & B, paratyphoid fever, typhoid fever etc.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of players, high investment in research & development, and availability of well-established healthcare infrastructure. Moreover, increasing prevalence of chronic diseases such as cancer and other infectious diseases are fueling the demand for RT-PCR techniques in this region.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as growing economy and rising disposable income leading to increased adoption of advanced diagnostic technologies resulting into an increase in demand for RT PCR kits over time. Furthermore, government initiatives encouraging R&D activities within emerging economies are anticipated to fuel growth during the forecast period (2018 - 2030). For instance ‘Genome Valley’ project was launched by Department Of Science And Technology (DST), Government Of India with an aim towards generating digital data through whole genome amplification technology which can be used for disease diagnosis & evolution studies etc.
Growth Factors:
- Increasing demand for accurate and rapid diagnosis of diseases
- Technological advancements in RT-PCR kits that offer enhanced performance
- Growing number of research institutes and laboratories that are using RT-PCR technology
- Rising prevalence of infectious diseases that require timely diagnosis
- Increasing funding for research on molecular diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
Reverse Transcription Polymerase Chain Reaction Kits Market Research Report
By Type
Quantitative Reverse Transcription Polymerase Chain Reaction Kits, Digital Reverse Transcription Polymerase Chain Reaction Kits
By Application
Hospitals, Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Others
By Companies
Roche, Merck(Sigma-Aldrich), Thermo Fisher Scientific, Qiagen N.V., Meridian Bioscience, Takara Bio Inc, Agilent Technologies, Abbott Laboratories, Altona Diagnostics, Bio-Rad Laboratories, Roche, Enzo Life Sciences, Inc, Cole-Parmer, Bioneer Corporation, Mylab Discovery Solutions, Biomérieux S.A
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Reverse Transcription Polymerase Chain Reaction Kits Market Report Segments:
The global Reverse Transcription Polymerase Chain Reaction Kits market is segmented on the basis of:
Types
Quantitative Reverse Transcription Polymerase Chain Reaction Kits, Digital Reverse Transcription Polymerase Chain Reaction Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Merck(Sigma-Aldrich)
- Thermo Fisher Scientific
- Qiagen N.V.
- Meridian Bioscience
- Takara Bio Inc
- Agilent Technologies
- Abbott Laboratories
- Altona Diagnostics
- Bio-Rad Laboratories
- Roche
- Enzo Life Sciences, Inc
- Cole-Parmer
- Bioneer Corporation
- Mylab Discovery Solutions
- Biomérieux S.A
Highlights of The Reverse Transcription Polymerase Chain Reaction Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Quantitative Reverse Transcription Polymerase Chain Reaction Kits
- Digital Reverse Transcription Polymerase Chain Reaction Kits
- By Application:
- Hospitals
- Diagnostic Centers
- Research Laboratories & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Reverse Transcription Polymerase Chain Reaction Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Reverse transcription polymerase chain reaction kits are a type of laboratory equipment used to amplify specific DNA sequences from a sample. This process is often used to identify the presence of specific genes or mutations in samples.
Some of the major players in the reverse transcription polymerase chain reaction kits market are Roche, Merck(Sigma-Aldrich), Thermo Fisher Scientific, Qiagen N.V., Meridian Bioscience, Takara Bio Inc, Agilent Technologies, Abbott Laboratories, Altona Diagnostics, Bio-Rad Laboratories, Roche, Enzo Life Sciences, Inc, Cole-Parmer, Bioneer Corporation, Mylab Discovery Solutions, Biom©rieux S.A.
The reverse transcription polymerase chain reaction kits market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Reverse Transcription Polymerase Chain Reaction Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Reverse Transcription Polymerase Chain Reaction Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Reverse Transcription Polymerase Chain Reaction Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Reverse Transcription Polymerase Chain Reaction Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Reverse Transcription Polymerase Chain Reaction Kits Market Size & Forecast, 2018-2028
4.5.1 Reverse Transcription Polymerase Chain Reaction Kits Market Size and Y-o-Y Growth
4.5.2 Reverse Transcription Polymerase Chain Reaction Kits Market Absolute $ Opportunity
Chapter 5 Global Reverse Transcription Polymerase Chain Reaction Kits Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Type
5.2.1 Quantitative Reverse Transcription Polymerase Chain Reaction Kits
5.2.2 Digital Reverse Transcription Polymerase Chain Reaction Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Reverse Transcription Polymerase Chain Reaction Kits Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.2.3 Research Laboratories & Academic Institutes
6.2.4 Pharmaceutical & Biotechnology Companies
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Reverse Transcription Polymerase Chain Reaction Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Reverse Transcription Polymerase Chain Reaction Kits Analysis and Forecast
9.1 Introduction
9.2 North America Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Type
9.6.1 Quantitative Reverse Transcription Polymerase Chain Reaction Kits
9.6.2 Digital Reverse Transcription Polymerase Chain Reaction Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.10.3 Research Laboratories & Academic Institutes
9.10.4 Pharmaceutical & Biotechnology Companies
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Reverse Transcription Polymerase Chain Reaction Kits Analysis and Forecast
10.1 Introduction
10.2 Europe Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Type
10.6.1 Quantitative Reverse Transcription Polymerase Chain Reaction Kits
10.6.2 Digital Reverse Transcription Polymerase Chain Reaction Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.10.3 Research Laboratories & Academic Institutes
10.10.4 Pharmaceutical & Biotechnology Companies
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Reverse Transcription Polymerase Chain Reaction Kits Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Type
11.6.1 Quantitative Reverse Transcription Polymerase Chain Reaction Kits
11.6.2 Digital Reverse Transcription Polymerase Chain Reaction Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.10.3 Research Laboratories & Academic Institutes
11.10.4 Pharmaceutical & Biotechnology Companies
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Reverse Transcription Polymerase Chain Reaction Kits Analysis and Forecast
12.1 Introduction
12.2 Latin America Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Type
12.6.1 Quantitative Reverse Transcription Polymerase Chain Reaction Kits
12.6.2 Digital Reverse Transcription Polymerase Chain Reaction Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.10.3 Research Laboratories & Academic Institutes
12.10.4 Pharmaceutical & Biotechnology Companies
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Reverse Transcription Polymerase Chain Reaction Kits Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Type
13.6.1 Quantitative Reverse Transcription Polymerase Chain Reaction Kits
13.6.2 Digital Reverse Transcription Polymerase Chain Reaction Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Reverse Transcription Polymerase Chain Reaction Kits Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.10.3 Research Laboratories & Academic Institutes
13.10.4 Pharmaceutical & Biotechnology Companies
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Reverse Transcription Polymerase Chain Reaction Kits Market: Competitive Dashboard
14.2 Global Reverse Transcription Polymerase Chain Reaction Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Merck(Sigma-Aldrich)
14.3.3 Thermo Fisher Scientific
14.3.4 Qiagen N.V.
14.3.5 Meridian Bioscience
14.3.6 Takara Bio Inc
14.3.7 Agilent Technologies
14.3.8 Abbott Laboratories
14.3.9 Altona Diagnostics
14.3.10 Bio-Rad Laboratories
14.3.11 Roche
14.3.12 Enzo Life Sciences, Inc
14.3.13 Cole-Parmer
14.3.14 Bioneer Corporation
14.3.15 Mylab Discovery Solutions
14.3.16 Biomérieux S.A
